Amgen (AMGN) Consolidated Net Income (2009 - 2026)

Amgen's Consolidated Net Income history runs 18 years deep, the most recent figure standing at $1.8 billion for Q1 2026.

• In Q1 2026, Consolidated Net Income rose 5.14% year-over-year to $1.8 billion; the TTM figure through Mar 2026 stood at $7.8 billion (up 31.47% YoY), while the FY2025 annual figure was $7.7 billion, up 88.53% from the prior year.
• Consolidated Net Income was $1.8 billion for Q1 2026 at Amgen, up from $1.3 billion in the prior quarter.
• In the past five years, Consolidated Net Income ranged from a high of $3.2 billion in Q3 2025 to a low of -$113.0 million in Q1 2024.
• Historically, Consolidated Net Income has averaged $1.6 billion across 5 years, with a median of $1.5 billion in 2022.
• The sharpest annual moves came in 2024 and 2025: Consolidated Net Income plunged 103.98% in 2024, then surged 1630.97% in 2025.
• A 5-year view of Consolidated Net Income shows it stood at $1.6 billion in 2022, then slumped by 52.54% to $767.0 million in 2023, then retreated by 18.25% to $627.0 million in 2024, then soared by 112.6% to $1.3 billion in 2025, then surged by 36.46% to $1.8 billion in 2026.
• The last three Consolidated Net Income figures came in at $1.8 billion (Q1 2026), $1.3 billion (Q4 2025), and $3.2 billion (Q3 2025), per Business Quant data.